Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.

White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Malte Lenders, Thomas Duning, Michael Schelleckes, Boris Schmitz, Sonja Stander, Arndt Rolfs, Stefan-Martin Brand, Eva Brand
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b9bc164e2a6a4760b4eb85b78da9ad09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b9bc164e2a6a4760b4eb85b78da9ad09
record_format dspace
spelling oai:doaj.org-article:b9bc164e2a6a4760b4eb85b78da9ad092021-11-18T07:58:46ZMultifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.1932-620310.1371/journal.pone.0055565https://doaj.org/article/b9bc164e2a6a4760b4eb85b78da9ad092013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23393592/?tool=EBIhttps://doaj.org/toc/1932-6203White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechanisms leading to WML in patients carrying the D313Y mutation in the α-galactosidase A (GLA) gene, a mutation that was formerly described as nonpathogenic. Pathogenic GLA mutations cause Fabry disease, a vascular endothelial glycosphingolipid storage disease typically presenting with a symptom complex of renal, cardiac, and cerebrovascular manifestations. We performed in-depths clinical, biochemical and genetic examinations as well as advanced magnetic resonance imaging analyses in a pedigree with the genetically determined GLA mutation D313Y. We detected exclusive neurologic manifestations of the central nervous system of the "pseudo"-deficient D313Y mutation leading to manifest WML in 7 affected adult family members. Furthermore, two family members that do not carry the mutation showed no WML. The D313Y mutation resulted in a normal GLA enzyme activity in leukocytes and severely decreased activities in plasma. In conclusion, our results provide evidence that GLA D313Y is potentially involved in neural damage with significant WML, demonstrating the necessity of evaluating patients carrying D313Y more thoroughly. D313Y might broaden the spectrum of hereditary small artery diseases of the brain, which preferably occur in young adults without classical risk factors. In view of the existing causal therapy regime, D313Y should be more specifically taken into account in these patients.Malte LendersThomas DuningMichael SchelleckesBoris SchmitzSonja StanderArndt RolfsStefan-Martin BrandEva BrandPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e55565 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Malte Lenders
Thomas Duning
Michael Schelleckes
Boris Schmitz
Sonja Stander
Arndt Rolfs
Stefan-Martin Brand
Eva Brand
Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
description White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechanisms leading to WML in patients carrying the D313Y mutation in the α-galactosidase A (GLA) gene, a mutation that was formerly described as nonpathogenic. Pathogenic GLA mutations cause Fabry disease, a vascular endothelial glycosphingolipid storage disease typically presenting with a symptom complex of renal, cardiac, and cerebrovascular manifestations. We performed in-depths clinical, biochemical and genetic examinations as well as advanced magnetic resonance imaging analyses in a pedigree with the genetically determined GLA mutation D313Y. We detected exclusive neurologic manifestations of the central nervous system of the "pseudo"-deficient D313Y mutation leading to manifest WML in 7 affected adult family members. Furthermore, two family members that do not carry the mutation showed no WML. The D313Y mutation resulted in a normal GLA enzyme activity in leukocytes and severely decreased activities in plasma. In conclusion, our results provide evidence that GLA D313Y is potentially involved in neural damage with significant WML, demonstrating the necessity of evaluating patients carrying D313Y more thoroughly. D313Y might broaden the spectrum of hereditary small artery diseases of the brain, which preferably occur in young adults without classical risk factors. In view of the existing causal therapy regime, D313Y should be more specifically taken into account in these patients.
format article
author Malte Lenders
Thomas Duning
Michael Schelleckes
Boris Schmitz
Sonja Stander
Arndt Rolfs
Stefan-Martin Brand
Eva Brand
author_facet Malte Lenders
Thomas Duning
Michael Schelleckes
Boris Schmitz
Sonja Stander
Arndt Rolfs
Stefan-Martin Brand
Eva Brand
author_sort Malte Lenders
title Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
title_short Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
title_full Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
title_fullStr Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
title_full_unstemmed Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
title_sort multifocal white matter lesions associated with the d313y mutation of the α-galactosidase a gene.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/b9bc164e2a6a4760b4eb85b78da9ad09
work_keys_str_mv AT maltelenders multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT thomasduning multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT michaelschelleckes multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT borisschmitz multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT sonjastander multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT arndtrolfs multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT stefanmartinbrand multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
AT evabrand multifocalwhitematterlesionsassociatedwiththed313ymutationoftheagalactosidaseagene
_version_ 1718422691772366848